CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-11 | Taneja Hemant Director | Sale | −6,232 | $198.91 | $1.2M | 373,981 |
| 2021-03-11 | Taneja Hemant Director | Sale | −620 | $199.81 | $124K | 373,361 |
| 2021-03-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +775 | $22.30 | $17K | 14,514 |
| 2021-03-10 | Trencher Daniel SVP Corporate Strategy | Sale | −3,000 | $196.30 | $589K | 11,514 |
| 2021-03-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −775 | 42,639 | ||
| 2021-03-08 | Turitz Andrew SVP - Business Development | Sale | −1,193 | $188.15 | $224K | 7,556 |
| 2021-03-05 | Verstraete Stephany Chief Marketing Officer | Sale | −4,463 | $183.18 | $818K | 22,278 |
| 2021-03-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −4,165 | $183.18 | $763K | 9,585 |
| 2021-03-05 | Turitz Andrew SVP - Business Development | Sale | −511 | $194.15 | $99K | 10,904 |
| 2021-03-05 | Turitz Andrew SVP - Business Development | Sale | −2,155 | $183.18 | $395K | 8,749 |
| 2021-03-05 | Trencher Daniel SVP Corporate Strategy | Sale | −2,383 | $183.18 | $437K | 13,739 |
| 2021-03-05 | GOREVIC JASON N Chief Executive Officer | Sale | −20,220 | $183.18 | $3.7M | 548,296 |
| 2021-03-05 | GOREVIC JASON N Chief Executive Officer | Option exercise | +8,190 | $12.21 | $100K | 556,486 |
| 2021-03-05 | GOREVIC JASON N Chief Executive Officer | Option exercise | +4,484 | $22.30 | $100K | 560,970 |
| 2021-03-05 | GOREVIC JASON N Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −8,190 | 383,649 | ||
| 2021-03-05 | GOREVIC JASON N Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −4,484 | 400,116 | ||
| 2021-03-04 | Verstraete Stephany Chief Marketing Officer | Sale | −956 | $200.48 | $192K | 18,229 |
| 2021-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +3,701 | 21,930 | ||
| 2021-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +4,811 | 26,741 | ||
| 2021-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Restricted Stock Units | −3,701 | 3,701 |
Page 75 of 93 · 1,848 trades